E-LIB Suche - Ergebnisse für: Aguirre, Luis E

1

Triple-Negative Myelofibrosis: Disease Features, Response t..:

Aguirre, Luis E. ; Jain, Akriti ; Ball, Somedeb...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 7 - p. 459-467 , 2024

Link: https://doi.org/10.1016/..

2

Clinical characteristics and outcomes of EZH2-mutant myelod..:

Ball, Somedeb ; Aguirre, Luis E. ; Jain, Akriti G....
Leukemia Research. 124 (2023) - p. 106999 , 2023

Link: https://doi.org/10.1016/..

3

Utilization of Serial Next-Generation Sequencing Among Pati..:

Jain, Akriti G. ; Ball, Somedeb ; Aguirre, Luis E....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 10 - p. e315-e322 , 2023

Link: https://doi.org/10.1016/..

4

U2AF1 and EZH2 mutations are associated with nonimmune hemo..:

Komrokji, Rami ; Aguirre, Luis E. ; Al Ali, Najla...
Blood Advances. 7 (2023) 1 - p. 1-8 , 2023

Link: https://doi.org/10.1182/..

5

POSTER: MDS-266 A Comprehensive Assessment of the Molecular..:

Aguirre, Luis E. ; Al Ali, Najla ; Sallman, David A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S181 , 2023

Link: https://doi.org/10.1016/..

6

P727: REFINING RISK STRATIFICATION IN CHRONIC MYELOMONOCYTI..:

Aguirre, Luis E. ; Jain, Akriti ; Ball, Somedeb...
HemaSphere. 7 (2023) S3 - p. e6555734 , 2023

Link: https://doi.org/10.1097/..

7

Sex Disparities in Myelodysplastic Syndromes: Genotype, Phe..:

Tinsley-Vance, Sara M ; Ali, Najla Al ; Ball, Somedeb...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 5 - p. 355-359 , 2023

Link: https://doi.org/10.1016/..

8

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM W..:

Komrokji, Rami S. ; Ball, Somdeb ; Maggioni, Giulia...
HemaSphere. 7 (2023) S3 - p. e616260d , 2023

Link: https://doi.org/10.1097/..

9

Activity of luspatercept and ESAs combination for treatment..:

Komrokji, Rami S. ; Aguirre, Luis E. ; Al Ali, Najla H....
Blood Advances. 7 (2023) 14 - p. 3677-3679 , 2023

Link: https://doi.org/10.1182/..

10

MDS-266 A Comprehensive Assessment of the Molecular Interna..:

Aguirre, Luis E. ; Al Ali, Najla ; Sallman, David A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S359-S360 , 2023

Link: https://doi.org/10.1016/..

11

Assessment and validation of the molecular international pr..:

Aguirre, Luis E. ; Al Ali, Najla ; Sallman, David A....
Leukemia. 37 (2023) 7 - p. 1530-1539 , 2023

Link: https://doi.org/10.1038/..

12

Drivers of deep molecular response and long‐term outcomes i..:

Patel, Parth C. ; Ball, Somedeb ; Jain, Akriti G....
American Journal of Hematology. 98 (2023) 12 - p. , 2023

Link: https://doi.org/10.1002/..

13

Poster: AML-488 Impact of Somatic Mutations on Treatment Re..:

Ball, Somedeb ; Jain, Akriti G ; Patel, Parth...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S136 , 2022

Link: https://doi.org/10.1016/..

14

AML-488 Impact of Somatic Mutations on Treatment Response a..:

Ball, Somedeb ; Jain, Akriti G ; Patel, Parth...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S256 , 2022

Link: https://doi.org/10.1016/..

15

Hypomethylating agent and venetoclax in patients with chron..:

Ball, Somedeb ; Jain, Akriti G. ; Aguirre, Luis E....
American Journal of Hematology. 97 (2022) 5 - p. , 2022

Link: https://doi.org/10.1002/..